Objective: The aim of this research is the effects of sedative drugs which are used on intensive care unit (ICU) patients on QT interval. Method: 90 patients who were hospitalized at ICU due to respiratory insufficiency and connected to mechanic ventilator were included. After the respiratory and cardiac monitorizations were enabled on patient with respiratory insufficiency in ICU, 12 derivations ECG's were recorded, systolic blood pressure (SBP), diastolic blood pressure(DBP), mean arterial blood pressure(MABP), heart rate(HR) and peripheric oxygen saturation (SpO2) values were recorded simultaneously. These values were used as base. At 1st and 12th hours of sedation (midazolam, propofol or dexmedetomidin), 12 derivations ECG's were recorded and again, SBP, DBP, MBP, HR and SpO2 values were recorded. ECG's were recorded at the speed of 25mm/s and at the height of 1 mV. Among the derivations in ECG recordings, the longest QT interval was measured by 2 anesthesiologists who don't know the groups and by measuring the RR interval on the same derivation, QTc (corrected QT) interval was measured with Bazzet formula. (QTc=QT intervali / √ RR interval) .Measured QT and QTc values were recorded. Results: When HR's at 12th hour were evaluated, HR at dexmedetomidin group was lower than both midazolam and propofol groups' HR and this was statistically significant (p<0,05). When MABP's at 12th hour were evaluated, MABP in propofol group was lower than dexmedetomidin group and this was statistically significant (p<0,05). When SpO2 values at 12th hour were evaluated, SpO2 values in midazolam group was significantly lower than the other 2 groups' SpO2 values. (p<0,05). For QT interval; dexmedetomidin prolonged the interval more than the other 2 agents both at 1st and 12th hours and this was statistically significant (p<0,05). There was statistically significant difference in QT intervals between propofol and midazolam groups at 12th hours (p<0,05). When QTc intervals were evaluated; only QTc values at 12th hour were different between different sedative agents and the QTc values in these groups belong to these different sedative agents were different each other and this was statistically different (p<0,05). Dexmedetomidin prolonged QTc mostly however propofol shows favorable efficacy by shortening the QTc interval. Conclusions: In our opinion, propofol is a good alternative sedative agent for dexmedetomidin and midazolam in patients with long QT interval because it shortens the QT interval however dexmedetomidin and midazolam can cause cardiac arrhythmia by prolonging QT interval. When making drug choice for sedation in ICU, patient's clinical situation, hemodynamic parameters and cardiac monitorization must be considered. Keywords: Propofol, midazolam, dexmedetomidine, sedation, QT interval, .
INTRODUCTION
Sedation is mostly needed for patients using mechanical ventilation (MV) in intensive care units (ICU) even if they are unconscious. In ICU, sedation is indicated for the treatment of anxiety (real or from psychophysiologic response caused by predicted danger) and agitation (excitability with body movements involved) 1 . In ICU, 40% of the patients state that they suffer from pain and 87% of them say that they feel discomfort 2 . Doses of the drugs that are used as routine and their superiority over eachother are still being discussed.
Ventilation support is commonly used on ICU patients to supply enough oxygenation 3, 4 and this is a reason for anxiety by itself. To get the optimum benefit from mechanical ventilation treatment and prevent incoherence with the ventilator, neuromuscular blockers should be used alongside sedative agents 5 . In addition, pain and agitation can cause immune-supression and hypercoagulopathy alongside an increase of oxygen consumption in the myocard.
Inefficient sedation of patients causes symptoms like hypertension, tachicardia, hypoxia and hypercapnia and struggling with the ventilator. On the other hand, excessive sedation can cause unwanted situations like hypotension, bradycardia, coma, respiration depression, ileus, renal failure, venose stasis, immune-supression 6, 7 . Another thing that can happen to ICU patients is agitation 8 .
These negative factors can be prevented by applying sedation. In addition, the time spent at both mechanical ventilation and ICU can be shortened. Despite the obvious clinical benefits of sedative agents, their side effects make the choice for the appropriate drug and its dose harder. In many trials, the effects (hemodynamic, respiratory, appropriate sedation, stress response, preventing agitation and the ability of usage over a long period of time) of drugs that are used in ICU have been evaluated.
Length of QT intervals is primarily controlled by late rectifying ventricular potassium current and blocking the fast component of this current with drugs is said to be the most important reason behind life threatening ''TORSADE DE POINTES''(twisting of the points) type arythmias (polymorphic ventricular tachicardias) 9 .
The goal of this study was to find out the effects of midazolam, propofol and dexmedetomidine infusion in ICU on QT intervals. 
METHOD

RESULTS
90 patients were included in the study. Of these patients, 35 (38,9%) were male, and 55 (61,1%) were female. The average age of these 90 patients was 72,6±15,4. Glasgow Coma Scale evaluation showed an average score of 7.71±2.66. When the groups were analyzed by age and gender range, the groups showed homogeneity within (Levene Test 0.053), and no significant difference was observed between the groups (p>0.05)( When we analyzed the effects of sedation type on heart rate, we could not find a significant difference between the sedative agents after 0 and 1 hours (p>0.05). After 12 hours, heart rates in the Midazolam and Propofol groups did not differ, however heart rates in the Dexmedetomidine group were significantly lower than the heart rates in the other two groups (p<0.05).
When we calculated the heart rates as a percentage of the initial heart rates and observed them by time,
we saw that after 1 hour, the heart rate was lowered by 7% by midazolam, 8% by propofol and 9% by dexmedetomidine, and that there were no significant differences between these changes. Whereas after 12 hours, decreases in heart rates were 11% for midazolam, 14% for propofol and 27% for dexmedetomidine. While heart rate changes in the Midazolam and Propofol groups did not differ, we saw that Dexmedetomidine lowered the heart rates significantly more than the other two groups (p<0.05)(Figure1).
Figure 1.
Change of patient's heart rates in percentage based on sedation type *The drop in heart rate caused by the same agent is significantly different than the heart rate at 0. hour (p<0.05). µ Difference between the decreases in heart rate caused by dexmedetomidine after 1 and 12 hours is significant (p<0.05).
When the effects of sedative agents on heart rate were evaluated in themselves, we saw that after 12 hours, heart rate deceleration of midazolam and propofol was significantly different than the deceleration after 0 and 1 hour.(p<0.05), and no significant difference was observed between 0. and 1. hour. But when the heart rate deceleration of dexmedetomidine was analyzed, we observed that the 12. hour deceleration was significantly different than both 0. and 1. hour heart rate (p<0.05)(Figure1).
When we analyzed the effects of sedation type on mean arterial pressure (MAP), no significant difference in MAP was found between various sedative agents after 0 and 1 hours (p>0.05). When MAPs were evaluated at 12. hour, no difference in MAPs between Midazolam and Dexmedetomidine groups were found, however the MAP in the Propofol group was significantly lower than the MAP in the Dexmedetomidine group (p<0.05) (Figure2). Figure 4 ). When the effects of sedative agents on SPO 2 were evaluated in themselves, we observed that there was a significant between 0. and 12. hour of Propofol and Dexmedetomidine (p<0.05). We could not find any significant difference between 0., 1. and 12. hour SPO 2 values in the Midazolam group (Figure4).
When we analyzed the effects of sedation type on QT and QTc, no significant difference was found between various sedative agents after 0 hour for QT intervals, and after 0 and 1 hours for QTc intervals (p>0.05). Dexmedetomidine extended QT intervals significantly more than the other 2 agents both after 1 and 12 hours (p<0.05). While there was no significant difference between midazolam and propofol after 1 hour, there was a significant difference between QT intervals in these 2 groups (p<0.05). When the QTc intervals were analyzed; only the 12. hour QTc values were different with various sedative agents and all the QTc values in these groups we significantly different (p<0.05) (Figure 5,6 ). When we calculated the QT and QTc values as a percentage of their initial values and observed them by time, we saw that after 1 hour, QT was extended by 2,6% by midazolam, and 10,3% by dexmedetomidine and shortened by 11% by propofol, and when these changes were compared to eachother, we observed that there was no significant difference between the midazolam and propofol groups and that there was a significant difference between midazolam-dexmedetomidine and propofol-dexmedetomidine groups (p<0.05) (Figure 7 ). After 1 hour, QTc was extended by 2,6% by midazolam and 10,3% by dexmedetomidine and shortened by 11% by propofol,and there was no significant difference between these changes. After 12 hours, QT was extended by 7% by midazolam and 13,4% by dexmedetomidine and shortened by 11% by propofol. QT intervals of all three sedative agent groups had significant difference after 12 hours (p<0.05). After 12 hours, QTc was extenden by 3,9% by midazolam and 10,3% by dexmedetomidine and shortened by 14% by propofol. QTc intervals of all three sedative agent groups were significantly different (p<0.05).
When the effects of sedative agents on QT and QTc intervals were evaluated in themselves, we observed a significant difference between propofol and dexmedetomidine 0. and 12. hours (p<0.05). There wasn't any significant difference between 0., 1. and 12. hours of midazolams QTc values (Figure 8 ). While Dexmedetomidine extended QTc intervals the most, Propofol showed positive activity by shortening it, let alone extending it. 
DISCUSSION
In the intensive care unit, tranquilisers like opiates, benzodiazepines, propofol and haloperidol are commonly used. All these agents are dose dependent sedatives. Dexmedetomidine, Midazolam and Propofol are frequently used in intensive care sedations. There are no studies where all three sedative agents are evaluated in hemodynamic, cardiac and oxygenation terms.
Midazolam, Propofol and Dexmedetomidine are frequently used for intensive care sedations in our clinic. These agents were also used in our study. In a study by Wunsch et al. In another study by Salluh et al., sedation applications of Brasilian intensive care doctors were analyzed andmore than half of the applicants received a sedation protocol, and midazolam (97,8%), fentanil (91,5%) and propofol (55%) were used commonly as sedatives 10 . Similar to our study; in a study by Kaygusuz et al. where hemodynamic and oxygen transportation effects of sedative agents with patients using mechanical ventilation in intensive care units were investigated, they observed that midazolam and propofol infusions caused drops in heart rate 11 . In another study by M. Hacer Ulger et al. where they used dexmedetomidine, they observed a drop in heart rate and atropine-responsive bradycardia in 3 patients 12 . A study by Tan et al. showed that the bradycardia incidence for dexmedetomidine was higher than the other agents 13 . Another study by Venn et al. where they compared the effects of dexmedetomidine and propofol on 20 intensive care patients, showed lower HR in the dexmedetomidine group than the propofol group 14 . Jalowiecki et al. observed higher bradycardia risk with dexmedetomidine in their study 15 . When dexmedetomidine and midazolam were compared for patients who were non-invasive mechanical ventilated, lower HR values were observed in the dexmedetomidine group. But distinctly from our study, midazolam HR values did not differ from their base values 16 . Likewise a study by Derbent et al. showed no changes in HR for propofol on intensive care patients using mechanical ventilation 17 . Another study where dexmedetomidine, midazolam and propofol were compared for neurosurgery patients who needed postoperative mechanical ventilation, showed that HR dropped with all 3 drugs, but there were no significant difference between them 18 . In our study, HR values dropped with dexmedetomidine, midazolam and propofol as well, but the drop in the dexmedetomidine group was significantly more. The study by Paliwal et al. where dexmedetomidine and midazolam were used for mechanical ventilated intensive care patients shows similar results to our study 19 .
Blood pressure changes in sedated patients should be monitored carefully, because intensive care patients usually consist of patients with limited cardiac reserve. In our study; mean arterial pressures (MAPs) were not significantly different between groups after 0 and 1 hours. However after 12 hours Propofol caused a more significant decrease in MAP. In all 3 groups after both 1 and 12 hours, MAP values were lower than their base values. This decrease was similar in all groups after 1 hour, and more obvious in the propofol group after 12 hours. It should be considered that the average age of included patients is relatively high and this could be the cause of hypotension. In a study by Bloor et al., 1mcg/kg dexmedetomidine infusion was applied to 6 healthy male volunteers for 2 minutes, and a significant decrease of 23% in blood pressure occured 20 . Arain et al. compared dexmedetomidine and propofol in their studies, and found that dexmedetomidine was superior because it caused less hypotension 21 . Weinbroum et al. reported that for intensive care patients, propofol caused more cardiovascular depression than midazolam 22 . Again similar to our study; dexmedetomidine and propofol were compared for sedation in mechanical ventilated IC patients in a study, and MAP values in both groups were lower than their base values. The decrease in the propofol group was more than the decrease in the dexmedetomidine group 19 .
Distinctly from our study; Tan et al. reported that there is no significant difference between dexmedetomidine and other sedative agents in terms of hypotension side effect 13 . A study by Venn et al. showed that there is no significant difference between dexmedetomidine and propofol when it comes to their effects on endocrine, metabolic, inflammatory and cardiac systems after a major surgery 14 . Dexmedetomidine, midazolam and propofol were applied to neurosurgery patients who needed mechanical ventilation in postoperative intensive care and compared in a study. MAP decreased with all 3 drugs, and this drop was similar for each of them 18 .
Mechanical ventilation is commonly used for intensive care patientsto provide enough oxygenation. To get the optimum benefit from mechanical ventilation treatment and prevent incoherence with the ventilator, sedative agents are used 4, 5 . Therefore sedative agents should have positive effects on intensive care patients with mechanical ventilator. We used SPO 2 in our study, which is an indicator for oxygenation. While sedation types did not show any differences in SPO 2 values after 0 and 1 hours, the SPO 2 values in propofol and dexmedetomidine groups were higher than the values in the midazolam group after 12 hours. While all sedative agents increased SPO 2 levels after 1 hour of sedation, the most obvious increase was with propofol after 12 hours. The least increase was with midazolam. Sedative agents increased the SPO 2 level as expected, but the singificant and obvious increase was with propofol. With these findings it can be said that the best results with mechanical ventilation can be achieved with propofol.
In a study by Gupta et 23 . This was also the case with our study, dexmedetomidine achieved higher SPO 2 levels than midazolam. In a study including 33 intensive care postoperative patients, Venn et al. reported that with dexmedetomidine sedation, paO 2 :FiO 2 ratio was higher than sedation without dexmedetomidine 24 . Huang et al. compared dexmedetomidine and midazolam in a study including 62 intensive care patients. After sedation with a Ramsey Sedation Score of 2-3, both groups had an increase in SpO 2 and PaO 2 :FiO 2 ratio. But this increase was not different from each other 25 .
There can be a lot of situations that can effect QT intervals in intensive care patients, like electrolyte anomalies. Especially hypokalemia, hypocalcemia and hypomagnesemia are frequently associated with QT prolongation 26 . Patients with electrolyte imbalances were excluded from our study. Many commonly used drugs in intensive cares are also associated with QT prolongation. Antiaritmics, antibiotics, antivirals, antiemetics, antidepressants, antipsychotics and narcotics have been reported to cause prolongation in QT dispersion 27 . While effects on QT of many drugs used for intensive care have been investigated, the effects of sedative agents which are commonly used in intensive cares are still unknown.
When we compared QT intervals of dexmedetomidine after both 1 and 12 hours with other agents, we observed that it extends the interval. After 12 hours, we saw that propofol shortened QT intervals. The variety of heart rates prevents the usage of QT intervals for determining arythmia risk. For this reason, corrected QT (QTc) interval is a more valuable parameter. There was no significant change in QTc intervals after 0 and 1 hours in our study. But after 12 hours of sedation, we observed a prolongation with dexmedetomidine, no change in midazolam and a shortage with propofol in QTc intervals. With the results of our study, we can say that dexmedetomidine should be used carefully because of its high mortal ventricular arythmia risk, and that propofol should be preferred because it shortens QTc intervals.
We could not find any research on sedative agents' effects on QT intervals for mechanically ventilated intensive care patients. For this reason, results in other areas of usage were used to compare dexmedetomidine, midazolam and propofol. In our study, propofol shortened QT intervals. In a 2005 study by Whyte et al. 28 on propofol use for children; they reported that propofol shortened QT intervals, and that it can be used safely even for children with long-QT syndrome. Especially the relationship between QT intervals and single dose of 0,2-5 mg/kg propofol induction were analyzed in studies done with inhalation anesthetics and propofol, and it was reported that this dose range does not extend QT and that propofol is safe for children with QT prolongation 29 . Similar to that, Hanci et al. 30 used sevofluran and propofol for anesthetic induction in their study, and reported no changes in QTc caused by propofol. Other researchers also reported that QT intervals do not change with propofol 31, 32 . Similar to our study, Higashijima et al. 33 did a study on 50 spinal surgery patients, where he compared thiamylal and propofol for induction, and reported a significant shortage of QT intervals caused by propofol. Kazanci et al. compared propofol, sevoflurane and desflurane in their study for induction on 46 general surgery patients and reported that propofol significantly shortens QT intervals 34 . There were no studies available that analyze QT intervals with the propofol doses we used. We think that studies reporting no QT interval changes with propofol support our results. Because in these studies, propofol was used for anesthetic induction, therefore with much higher doses than ours. Distinctly from this study, Kim et al. researched the effects of target controlled propofol infusion on QTc intervals in their study, and reported that QTc values extended significantly compared to the base values during propofol infusion and endotracheal intubation 35 . In another study by Saarnivaara et al. which included 123 pediatric patients, propofol was reported to extend QT intervals 36 . In a study where Michaloudis et al. used midazolam and propofol on 30 patients for anesthetic induction, they observed no QT interval changes for both of the agents 37 . Results from their study coincide with the results from our study. In another study by Michaloudis et al. in 1995, they reported that midazolam did not change QT intervals 38 . Similar to that, a study including 40 patients done by Owczuk et al. showed that midazolam did not effect QT intervals 39 .
Apart from a few studies where dexmedetomidine's effects on QT intervals were investigated, no other studies are available. In 2008, during a pediatric ablation and electrophysiologic study by Hammer et al., a deceleration in sinus and atrioventricular node and a significant QTc prolongation were observed. They have reached the conclusion that the usage of dexmedetomidine on patients with bradyarythmia tendency increases the risk of QT interval prolongation 40 .Their results are similar to our study's results. Distinctly from our study's results; Chrysostomou et al. researched electrocardiographic effects of dexmedetomidine on 0-17 year old pediatric intensive care patients. They reported that dexmedetomidine has no effect on QT intervals 41 . Likewise, in a study by Reade et al, haloperidol and dexmedetomidine were applied to 20 mechanical ventilated patients in intensive care. They observed that dexmedetomidine did not cause a significant QT interval prolongation 42 .
We reached a conclusion that for intensive care sedations, the following agents should be preferred: dexmedetomidine if the patient has tachycardia, propofol if their blood pressure is high, midazolam if their blood pressure and heart rate are low, propofol if their oxygenation is insufficient due to incoherence with mechanical ventilator and again propofol if they have long QT intervals.
